Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: Implications for cervical disease

British Journal of Cancer

Volumn 86, Issue 2, 2002, Pages 269-273

  Kammer C ^a   Tommasino, M ^b   Syrjanen S ^c   Delius, H ^b   Hebling, U ^b   Warthorst, U ^a   Pfister, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Cervical disease; E6 oncogene; Human papillomavirus 16; Long control region; Viral variant

Indexed keywords

LUCIFERASE; ONCOPROTEIN;

ARTICLE; CANCER GRADING; CARCINOGENICITY; CLINICAL ARTICLE; DNA POLYMORPHISM; EUROPE; FEMALE; GENE ACTIVITY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS ONCOGENE; VIRUS TYPING; WART VIRUS;

ADULT; EUROPE; FEMALE; HUMANS; INCIDENCE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0037148421     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600024     Document Type: Article

References (20)

1. The enhancer of human papillomavirus type 16: Binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription
2. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers
3. Human papillomavirus type 16 variants and risk of cervical cancer
4. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity
5. Variants of the long control region of human papillomavirus type 16
6. Uniform distribution of HPV16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer
7. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity
8. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein
9. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
10. Human papillomavirus type 16 DNA sequence
11. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16
12. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
13. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
14. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
15. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective
16. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms
17. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype
18. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development
19. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes
20. Human papillomaviruses in the pathogenesis of anogenital cancer